News Briefing channel feed – Endpoints News

News Briefing channel feed

Daré does a reverse merger with an ailing Cerulean; Pulmocide raises $30.4M for RSV therapy

9 years ago

AveXis shares spike on more positive data for SMA gene therapy; Biogen stock tanks on fresh skepticism

9 years ago

Biogen recruits Roche vet Ghosh as head of research, early development; Cell Medica raises £60 million; Aerpio bags $40M raise

9 years ago

Clozel’s Actelion R&D spinout gets a name; GSK’s new CEO won’t make as much as her predecessor

9 years ago

Sanofi and Regeneron score early access for dupilumab in UK; Sanders skewers Sanofi on Zika vaccine

9 years ago

Daiichi Sankyo forges $12M pact for GPCR pain program with Heptares; Incyte shares jump on latest takeover chatter

9 years ago

Gottlieb continues to be Trump's leading candidate for FDA; BeyondSpring completes unusual IPO

9 years ago

OncoResponse wraps Series A with $22.5M; Plotting IPO, BerGenBio partners with Merck on cancer combos

9 years ago

Soon-Shiong blasts back at “maliciously false” STAT story; ImmunoMet raises $5M

9 years ago

Soon-Shiong’s NantHealth tanks on STAT report of self-dealing; Bioversys, Aptuit forge antibiotic collab; Helix gets new CEO

9 years ago

GSK vet named CEO of China CAR-T JV with Kite; Coherus fights back against Amgen claims it stole trade secrets

9 years ago

Buyout buzz centers on a Novartis NASH deal for Genfit; Synthon joins the CD47 club

9 years ago

Bluebird’s star gene therapy patient still doing well after 15 months-plus; Takeda, Arix partner on biotech startups

9 years ago

Grail grabs $900M-plus in Series B; Alnylam’s givosiran makes PRIME time

9 years ago

Merck KGaA, Pfizer win another quick FDA review for avelumab; WHO tries to spur more incentives for antibiotics R&D

9 years ago

Pieris inks a licensing deal for Japan; Kindler joins Pharma Two B board with $30M raise; Ampio plots new pain study

9 years ago

AstraZeneca gets a thumbs-up for ZS-9 in Europe; Tocagen wins a BTD for brain cancer drug

9 years ago

J&J leads a $25M A round for cancer startup; BMJ frets about Trump’s impact on the scientific community

9 years ago

PhRMA chief plays favorites in singling out Martin Shkreli as a ‘bad actor’; Roche extends antibiotics collaboration

9 years ago

Neovacs signs €65M China deal; Another biotech CEO chatters on about a possible buyout

9 years ago

Arix IPO raises £100M for new biotech investments; Santhera sets up shop in Massachusetts

9 years ago

Alkermes CEO Pops stays focused on 5461 filing plans; Shkreli gets booed at Harvard

9 years ago

Ionis bags a $75M milestone from Bayer; Inventiva garners $51M from IPO

9 years ago

Martin Shkreli continues college tour with stops at Harvard, UMass; Vernalis picks up $3M milestone

9 years ago

First page Previous page 71 72 737475 76 77 Next page Last page